$0.43
0.45%
Nasdaq, Nov 06, 04:00 pm EST. Closed.
ISIN
US7574681034
Symbol
RDHL

RedHill Biopharma Ltd. Sponsored ADR Stock price

$0.43
-0.06 11.59% 1M
-0.59 58.05% 6M
-0.60 58.46% YTD
-0.73 63.11% 1Y
-8.19 95.04% 3Y
-5,099.57 99.99% 5Y
-11,759.57 100.00% 10Y
-11,099.57 100.00% 20Y
Nasdaq, Closing price Fri, Nov 06 2026
+0.00 0.45%
ISIN
US7574681034
Symbol
RDHL
Industry

Is RedHill Biopharma Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
$3.8m
Enterprise Value
$850.0k
Net debt
positive
Cash
$4.0m
Shares outstanding
50.9b
Valuation
P/E
-
P/S | estimate
0.9 | -
EV/Sales | estimate
0.2 | -
EV/FCF | ex SBC
negative | -
P/B
0.9
Financial Health
Equity Ratio
16.8%
Return on Equity
-10.1%
ROCE
-200.4%
ROIC
-
Debt/Equity
0.3
Financials
Revenue | estimate
$4.4m | -
EBITDA
$-11.9m
EBIT
$-12.3m
Net Income
$-4.6m
Free Cash Flow | ex SBC
$-9.7m | -
Growth
Revenue | estimate
-58.9% | -
EBITDA
47.1%
EBIT
46.7%
Net Income
59.9%
Free Cash Flow
-3.0%
Margin
Gross
-
EBITDA
-272.1%
EBIT
-281.5%
Net
-104.5%
Free Cash Flow | ex SBC
-221.2% | -
More
EPS
$0.0
FCF per Share
$0.0
Short interest
1.5%
Employees
35
Rev per Employee
$10.0k

RedHill Biopharma Ltd. Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a RedHill Biopharma Ltd. Sponsored ADR forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a RedHill Biopharma Ltd. Sponsored ADR forecast:

Buy
86%
Hold
14%

Financial data from RedHill Biopharma Ltd. Sponsored ADR

Dec '25
+/-
%
4.37 4.37
59% 59%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 12 12
51% 51%
276%
- Research and Development Expense 2.99 2.99
33% 33%
68%
-12 -12
47% 47%
-272%
- Depreciation and Amortization 0.41 0.41
34% 34%
9%
EBIT (Operating Income) EBIT -12 -12
47% 47%
-281%
Net Profit -4.56 -4.56
60% 60%
-104%

In millions USD.

Don't miss a Thing! We will send you all news about RedHill Biopharma Ltd. Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

RedHill Biopharma Ltd. Sponsored ADR Stock News

Neutral
PRNewsWire
●
5 days ago
In vitro studies, undertaken by two leading microbiology centers, confirm RHB-204's killing capability on Mycobacterium avium subspecies paratuberculosis (MAP) and its MAP-killing comparability to RedHill's RHB-104 in both long-term intracellular culture and spot and phage assays The two sets of studies, showing confirmed MAP-killing effect and comparability to RHB-104, led by Professor Tim Bul...
Neutral
PRNewsWire
●
19 days ago
TEL AVIV, Israel and RALEIGH, N.C., Oct. 19, 2026 /PRNewswire/ -- RedHill Biopharma Ltd.
Neutral
PRNewsWire
●
about one month ago
Executing a full strategic portfolio reset, RedHill is now a stronger commercial entity with Rebyota® and Clenpiq®, two established FDA-approved gastrointestinal (GI) brands that generated $37.5 million in 2025 net sales under Ferring Pharmaceuticals ("Ferring"), an advanced late-stage pipeline and a fully-controlled commercial infrastructure with capacity for portfolio expansion TEL AVIV, Isra...
More RedHill Biopharma Ltd. Sponsored ADR News

Company Profile

RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Head office Israel
CEO Mr. Ben-Asher
Employees 35
Founded 2009
Website www.redhillbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today